Dr. Hsu is a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in
partnership with Michigan State University and the National Cancer Institute, July 2018 - present.
Prior to joining the program, Dr. Hsu received his D.V.M. in May of 2018 from the University of
California, Davis. He completed his diagnostic pathology training at Michigan State University in East Lansing, Michigan, and has joined the Durum Laboratory at the NCI. His research interests include understanding the molecular mechanism of oncogenesis, oncogene collaboration, and the development of targeted therapies. His current research focuses on the collaboration between a mutant hIL7Rα and overexpression of RasGRP1 in a mouse model of T cell acute lymphoblastic leukemia.
